Aliskiren/HCTZ

DRUG2 trials

Sponsors

Novartis

Conditions

Hypertension

Phase 3

A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients

CompletedNCT00386139

NovartisHypertension

Start: 2006-09-30End: 2007-07-31Updated: 2017-02-07

Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension

CompletedNCT00387517

NovartisHypertension

Start: 2006-10-31End: 2007-08-31Target: 726Updated: 2017-02-07